Works matching DE "RALOXIFENE"

Results: 778

Chemoprevention of Breast Cancer in Postmenopausal Women.

Published in:

Breast Disease, 2005, v. 24, n. 1, p. 79

By:

Geller, Brian A.;
Vogel, Victor G.

Publication type:

Article

PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.

Published in:

Osteoporosis International, 2025, v. 36, n. 6, p. 951, doi. 10.1007/s00198-025-07440-1

By:

Beaudart, Charlotte;
Veronese, Nicola;
Douxfils, Jonathan;
Thiyagarajan, Jotheeswaran Amuthavalli;
Bolzetta, Francesco;
Albanese, Paolo;
Voltan, Gianpaolo;
Alokail, Majed;
Harvey, Nicholas C.;
Fuggle, Nicholas R.;
Bruyère, Olivier;
Rizzoli, René;
Reginster, Jean-Yves

Publication type:

Article

ODAC Recommends Approval of Raloxifene to Reduce Risk of Invasive Breast Cancer.

Published in:: Oncology (08909091), 2007, v. 21, n. 9, p. 1152
Publication type:: Article

A STAR Is Born.

Published in:

Oncology (08909091), 2006, v. 20, n. 9, p. 1126

By:

Jordan, V. Craig

Publication type:

Article

STAR Trial Shows Raloxifene to Be as Effective as Tamoxifen in Preventing Invasive Breast Cancer.

Published in:: Oncology (08909091), 2006, v. 20, n. 6, p. 648
Publication type:: Article

Use of the Gail Model and Breast Cancer Preventive Therapy Among Three Primary Care Specialties.

Published in:

2014

By:

Corbelli, Jennifer;
Borrero, Sonya;
Bonnema, Rachel;
McNamara, Megan;
Kraemer, Kevin;
Rubio, Doris;
Karpov, Irina;
McNeil, Melissa

Publication type:

Journal Article

The role of encapsulation by β-cyclodextrin in the interaction of raloxifene with macromolecular targets: a study by spectroscopy and molecular modeling.

Published in:

Journal of Biological Physics, 2014, v. 40, n. 4, p. 347, doi. 10.1007/s10867-014-9355-y

By:

Sameena, Y.;
Sudha, N.;
Chandrasekaran, S.;
Enoch, Israel

Publication type:

Article

One versus 2 years of alendronate following denosumab: the CARD extension.

Published in:

Osteoporosis International, 2024, v. 35, n. 12, p. 2225, doi. 10.1007/s00198-024-07213-2

By:

Tsai, Joy N.;
Jordan, Mackenzie;
Lee, Hang;
Leder, Benjamin Z.

Publication type:

Article

Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023.

Published in:

Osteoporosis International, 2024, v. 35, n. 8, p. 1451, doi. 10.1007/s00198-024-07120-6

By:

Knight, K.J.;
Fordham, R.J.;
Crabtree, N.J.;
Knapp, K.M.

Publication type:

Article

Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.

Published in:

2024

By:

Ramchand, Sabashini K.;
Tsai, Joy N.;
Lee, Hang;
Sassana-Khadka, Grace;
Jordan, Mackenzie;
Ryan, Savannah;
Leder, Benjamin Z.

Publication type:

Correction Notice

The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.

Published in:

Osteoporosis International, 2024, v. 35, n. 2, p. 255, doi. 10.1007/s00198-023-06932-2

By:

Ramchand, Sabashini K.;
Tsai, Joy N.;
Lee, Hang;
Sassana-Khadka, Grace;
Jordan, Mackenzie;
Ryan, Savannah;
Leder, Benjamin Z.

Publication type:

Article

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.

Published in:

Osteoporosis International, 2022, v. 33, n. 7, p. 1591, doi. 10.1007/s00198-022-06388-w

By:

Ha, J.;
Kim, J.;
Jeong, C.;
Lim, Y.;
Kim, M. K.;
Kwon, H.-S.;
Song, K.-H.;
Kang, M. I.;
Baek, K.-H.

Publication type:

Article

Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.

Published in:

Osteoporosis International, 2021, v. 32, n. 12, p. 2473, doi. 10.1007/s00198-021-05951-1

By:

Singer, A.J.;
Liu, J.;
Yan, H.;
Stad, R.K.;
Gandra, S.R.;
Yehoshua, A.

Publication type:

Article

Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.

Published in:

Osteoporosis International, 2018, v. 29, n. 8, p. 1875, doi. 10.1007/s00198-018-4560-3

By:

Hoff, M.;
Skurtveit, S.;
Meyer, H.E.;
Langhammer, A.;
Søgaard, A.J.;
Syversen, U.;
Skovlund, E.;
Abrahamsen, B.;
Forsmo, S.;
Schei, B.

Publication type:

Article

Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.

Published in:

Osteoporosis International, 2017, v. 28, n. 3, p. 1109, doi. 10.1007/s00198-016-3812-3

By:

Kimura, S.;
Saito, M.;
Kida, Y.;
Seki, A.;
Isaka, Y.;
Marumo, K.

Publication type:

Article

Alendronate- and risedronate-induced acute polyarthritis.

Published in:

Osteoporosis International, 2016, v. 27, n. 11, p. 3383, doi. 10.1007/s00198-016-3695-3

By:

Uğurlar, M.

Publication type:

Article

Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia.

Published in:

Osteoporosis International, 2016, v. 27, n. 8, p. 2585, doi. 10.1007/s00198-016-3573-z

By:

Naylor, K.;
Jacques, R.;
Peel, N.;
Gossiel, F.;
Eastell, R.

Publication type:

Article

Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.

Published in:

Osteoporosis International, 2016, v. 27, n. 6, p. 1989, doi. 10.1007/s00198-015-3476-4

By:

Amiche, M.;
Albaum, J.;
Tadrous, M.;
Pechlivanoglou, P.;
Lévesque, L.;
Adachi, J.;
Cadarette, S.

Publication type:

Article

Biological agents in management of osteoporosis.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 11, p. 1291, doi. 10.1007/s00228-014-1735-5

By:

Tella, Sri;
Gallagher, J.

Publication type:

Article

Prescription of anti-osteoporosis drugs during 2004–2007—a nationwide register study in Norway.

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 3, p. 299, doi. 10.1007/s00228-009-0746-0

By:

Devold, Helene;
Doung, Gia;
Tverdal, Aage;
Furu, Kari;
Meyer, Haakon;
Falch, Jan;
Sogaard, Anne

Publication type:

Article

Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment.

Published in:

Medical Principles & Practice, 2009, v. 19, n. 1, p. 68, doi. 10.1159/000252838

By:

Matsumura, Mihoko;
Monden, Tsuyoshi;
Nakatani, Yuki;
Shimizu, Hiroaki;
Domeki, Nozomi;
Yanagi, Kazunori;
Ikeda, Shiori;
Kawagoe, Yoshiaki;
Kasai, Kikuo

Publication type:

Article

Estrogen Receptor Profiles: Changes in Mouse and Rat Mammary Tumors by Treatment with Selective Estrogen Receptor Modifiers.

Published in:

Medical Principles & Practice, 2004, v. 13, n. 4, p. 220, doi. 10.1159/000078320

By:

Actis, A. M.;
Cocca, C. M.;
Gutierrez, A.;
Croci, M.;
Rivera, E. S.;
Bergoc, R. M.

Publication type:

Article

The Beneficial and Adverse Effects of Raloxifene in Menopausal Women: A Mini Review.

Published in:

Journal of Menopausal Medicine, 2018, v. 24, n. 3, p. 183, doi. 10.6118/jmm.2018.24.3.183

By:

Khorsand, Imaneh;
Kashef, Reyhaneh;
Ghazanfarpour, Masumeh;
Mansouri, Elaheh;
Dashti, Sareh;
Khadivzadeh, Talat

Publication type:

Article

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women.

Published in:

Journal of Menopausal Medicine, 2017, v. 23, n. 1, p. 56, doi. 10.6118/jmm.2017.23.1.56

By:

Mi Jung Um;
Cho, Eun A.;
Hyuk Jung

Publication type:

Article

THE RADIOLOGICAL ANALYSIS OF THE EFFECTS OF RALOXIFENE, NITRIC-OXIDE AND ESTROGEN ON SCOLIOSIS: A BIPEDAL C57BL6 MICE MODEL.

Published in:

Journal of Turkish Spinal Surgery, 2020, v. 31, n. 4, p. 201, doi. 10.4274/jtss.galenos.2020.329

By:

BAŞ, Can Emre;
AKEL, İbrahim;
DEMİRKIRAN, Halil Gökhan;
ACAROĞLU, Rıfat Emre

Publication type:

Article

Antiosteoporosis Medication Prescriptions After Fragility Fractures.

Published in:

JAMA Network Open, 2024, v. 7, n. 10, p. e2438393, doi. 10.1001/jamanetworkopen.2024.38393

By:

Silverstein, William K.;
Wang, Sping;
Alavinejad, Mahnaz;
Sarnocinska, Ania;
Stall, Nathan M.;
Malikov, Kamil;
Hillmer, Michael P.;
Zipursky, Jonathan S.

Publication type:

Article

358. SUBSTRATE-DEPENDENT DRUG INTERACTION WITH CYP3A4 IRREVERSIBLE INACTIVATORS.

Published in:: 2002
Publication type:: Abstract

14. UDP-GLUCURONOSYLTRANSFERASE-SPECIFIC GLUCURONIDATION INACTIVATES 4-HYDROXYTAMOXIFEN AND RALOXIFENE.

Published in:: 2002
Publication type:: Abstract

Efflux and uptake transport and gut microbial reactivation of raloxifene glucuronides.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2025, v. 136, n. 1, p. 1, doi. 10.1111/bcpt.14107

By:

Uoti, Arttu;
Kurkela, Mika;
Niemi, Mikko;
Oksanen, Timo;
Oswald, Stefan;
Puustinen, Lauri;
Kidron, Heidi;
Sjöstedt, Noora

Publication type:

Article

Management of osteoporosis update.

Published in:

Journal of Community Nursing, 2013, v. 27, n. 2, p. 4

By:

Ashcroft-Hands, Rachel

Publication type:

Article

A Comparison of the Adjunctive Administration of Raloxifene and Isradipine in Reducing Cognitive Deficits of Patients with Schizophrenia.

Published in:

Iranian Journal of Psychiatry & Behavioral Sciences / Progress in Psychiatry & Behavioral Sciences, 2018, p. 168

By:

Vahdani, B.;
Armani kian, A.;
Esmaeilzadeh, A.;
Zenoozian, S.;
Mazloomzadeh, S.

Publication type:

Article

A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis.

Published in:

Life (2075-1729), 2025, v. 15, n. 4, p. 581, doi. 10.3390/life15040581

By:

Shyam Sundar, Pottabathula;
Selvaraj, Jubie;
Alagarsamy, Veerachamy;
Solomon, Viswas Raja;
Natarajan, Jawahar

Publication type:

Article

Hemostatic Effects of Raloxifene in Ovariectomized Rats.

Published in:

Life (2075-1729), 2023, v. 13, n. 7, p. 1612, doi. 10.3390/life13071612

By:

Alva-Chavarría, Denys;
Soto-Núñez, Maribel;
Flores-Soto, Edgar;
Jaimez, Ruth

Publication type:

Article

Combination Therapy of PTH and Antiresorptive Drugs on Osteoporosis: A Review of Treatment Alternatives.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.607017

By:

Zhang, Chenggui;
Song, Chunli

Publication type:

Article

Selective Estrogen Receptor Modulator-Like Activities of Herba epimedii Extract and its Interactions With Tamoxifen and Raloxifene in Bone Cells and Tissues.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.571598

By:

Zhou, Liping;
Wong, Ka-Ying;
Yu, Wenxuan;
Poon, Christina Chui-Wa;
Xiao, Huihui;
Chan, Chi-On;
Mok, Daniel Kam-Wah;
Zhang, Yan;
Wong, Man-Sau

Publication type:

Article

Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient.

Published in:

2012

By:

Morales, Enrique;
Morales, Rafael;
Gutiérrez, Eduardo;
Rojas-Rivera, Jorge;
Praga, Manuel

Publication type:

Case Study

Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene.

Published in:

Cell Proliferation, 2010, v. 43, n. 2, p. 124, doi. 10.1111/j.1365-2184.2009.00664.x

By:

Lopes-Costa, P. V.;
dos Santos, A. R.;
dos Santos, L. G.;
da Silva, B. B.

Publication type:

Article

Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women.

Published in:

Cell Proliferation, 2009, v. 42, n. 4, p. 506, doi. 10.1111/j.1365-2184.2009.00615.x

By:

da Silva, B. B.;
dos Santos, A. R.;
Pires, C. G.;
Lopes-Costa, P. V.

Publication type:

Article

My Lived Experiences Are More Important Than Your Probabilities.

Published in:

Medical Decision Making, 2015, v. 35, n. 8, p. 1010, doi. 10.1177/0272989X15594382

By:

Holmberg, Christine;
Waters, Erika A.;
Whitehouse, Katie;
Daly, Mary;
McCaskill-Stevens, Worta

Publication type:

Article

The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density.

Published in:

Drugs, 2021, v. 81, n. 16, p. 1831, doi. 10.1007/s40265-021-01625-8

By:

van der Burgh, Anna C.;
de Keyser, Catherine E.;
Zillikens, M. Carola;
Stricker, Bruno H.

Publication type:

Article

Raloxifene: A Review of its Use in the Prevention of Invasive Breast Cancer.

Published in:

Drugs, 2008, v. 68, n. 14, p. 2069

By:

Moen, Marit D.;
Keating, Gillian M.

Publication type:

Article

Current Pharmacological Options for the Management of Primary Hyperparathyroidism.

Published in:

Drugs, 2006, v. 66, n. 17, p. 2189, doi. 10.2165/00003495-200666170-00004

By:

Vestergaard, Peter

Publication type:

Article

Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial.

Published in:

Orthopaedic Surgery, 2020, v. 12, n. 4, p. 1074, doi. 10.1111/os.12696

By:

Gong, Long;
Zhang, Yao‐yao;
Yang, Na;
Qian, Huan‐juan;
Zhang, Ling‐kun;
Tan, Ming‐sheng

Publication type:

Article

골다공증의 약물치료.

Published in:

Journal of the Korean Medical Association / Taehan Uisa Hyophoe Chi, 2016, v. 59, n. 11, p. 847, doi. 10.5124/jkma.2016.59.11.847

By:

민 용 기

Publication type:

Article

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride.

Published in:

2021

By:

Norimatsu, Yurie;
Norimatsu, Yuta

Publication type:

Case Study

Raloxifene Protects Cisplatin-Induced Renal Injury in Mice via Inhibiting Oxidative Stress.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4879, doi. 10.2147/OTT.S314810

By:

An, Jian-Hong;
Li, Chun-Yan;
Chen, Chun-Ya;
Wu, Jian-Bin;
Shen, Hong

Publication type:

Article

Profiling the SERM patient.

Published in:

Obstetrics & Gynaecology Forum, 2012, v. 22, n. 2, p. 36

By:

de Villiers, Tobie

Publication type:

Article

Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride.

Published in:

Scientia Pharmaceutica, 2012, v. 80, n. 3, p. 605, doi. 10.3797/scipharm.1204-13

By:

Reddy, Reguri Buchi;
Goud, Thirumani Venkateshwar;
Nagamani, Nagabushanam;
Kumar, Nutakki Pavan;
Alagudurai, Anandan;
Murugan, Raman;
Parthasarathy, Kannabiran;
Karthikeyan, Vinayagam;
Balaji, Perumal

Publication type:

Article

Endometrial hysteroscopic and histological evaluation in menopausal women in continuous use of raloxifene.

Published in:

Einstein (16794508), 2010, v. 8, n. 1, p. 29, doi. 10.1590/s1679-45082010ao1227

By:

Soares, Vanessa Maria Caetano;
Martorelli Filho, Braz;
Fernandes, Luiz Roberto Araujo;
Lippi, Umberto Gazi

Publication type:

Article

The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.

Published in:

PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0196419

By:

Chiu, Wei-Yih;
Yang, Wei-Shiung;
Chien, Jung-Yien;
Lee, Jang-Jaer;
Tsai, Keh-Sung

Publication type:

Article